BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 2016;96:1127-68. [PMID: 27335447 DOI: 10.1152/physrev.00019.2015] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 32.2] [Reference Citation Analysis]
Number Citing Articles
1 Broughton KM, Sussman MA. Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells. Circ Res 2018;123:177-87. [PMID: 29976686 DOI: 10.1161/CIRCRESAHA.118.311207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
2 Chen C, Wang D, Moshaverinia A, Liu D, Kou X, Yu W, Yang R, Sun L, Shi S. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res 2017;27:559-77. [PMID: 28106077 DOI: 10.1038/cr.2017.11] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
3 Follin B, Hoeeg C, Højgaard LD, Juhl M, Lund KB, Døssing KBV, Bentsen S, Hunter I, Nielsen CH, Ripa RS, Kastrup J, Ekblond A, Kjaer A. The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic Cardiomyopathy. Int J Mol Sci 2021;22:11758. [PMID: 34769184 DOI: 10.3390/ijms222111758] [Reference Citation Analysis]
4 Docshin PM, Karpov AA, Eyvazova SD, Puzanov MV, Kostareva AA, Galagudza MM, Malashicheva AB. Activation of Cardiac Stem Cells in Myocardial Infarction. Cell Tiss Biol 2018;12:175-82. [DOI: 10.1134/s1990519x18030045] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yaghoubi A, Azarpira N, Karbalay-Doust S, Daneshi S, Vojdani Z, Talaei-Khozani T. Prednisolone and mesenchymal stem cell preloading protect liver cell migration and mitigate extracellular matrix modification in transplanted decellularized rat liver. Stem Cell Res Ther 2022;13:36. [PMID: 35090559 DOI: 10.1186/s13287-022-02711-8] [Reference Citation Analysis]
6 Peng C, Li Y, Lu L, Zhu J, Li H, Hu J. Efficient One-Step Induction of Human Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) Produces MSC-Derived Neurospheres (MSC-NS) with Unique Transcriptional Profile and Enhanced Neurogenic and Angiogenic Secretomes. Stem Cells Int 2019;2019:9208173. [PMID: 31933651 DOI: 10.1155/2019/9208173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tang Y, Li J, Wang W, Chen B, Chen J, Shen Z, Hou J, Mei Y, Liu S, Zhang L, Li Z, Lu S. Platelet extracellular vesicles enhance the proangiogenic potential of adipose-derived stem cells in vivo and in vitro. Stem Cell Res Ther 2021;12:497. [PMID: 34503551 DOI: 10.1186/s13287-021-02561-w] [Reference Citation Analysis]
8 Ni J, Sun Y, Liu Z. The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases. J Cardiovasc Transl Res 2019;12:51-61. [PMID: 29525884 DOI: 10.1007/s12265-018-9799-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
9 Yin L, Huang D, Liu X, Wang Y, Liu J, Liu F, Yu B. Omentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro. Stem Cell Res Ther. 2017;8:224. [PMID: 29017592 DOI: 10.1186/s13287-017-0676-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
10 Deng J, Zhang N, Wang Y, Yang C, Wang Y, Xin C, Zhao J, Jin Z, Cao F, Zhang Z. FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction. Stem Cell Res Ther 2020;11:228. [PMID: 32522253 DOI: 10.1186/s13287-020-01746-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Arzaghi H, Rahimi B, Adel B, Rahimi G, Taherian Z, Sanati AL, Shiralizadeh Dezfuli A. Nanomaterials modulating stem cell behavior towards cardiovascular cell lineage. Mater Adv 2021;2:2231-62. [DOI: 10.1039/d0ma00957a] [Cited by in Crossref: 10] [Article Influence: 10.0] [Reference Citation Analysis]
12 Blocki A, Löper F, Chirico N, Neffe AT, Jung F, Stamm C, Lendlein A, Jünger M, Krüger-genge A, Jung F. Engineering of cell-laden gelatin-based microgels for cell delivery and immobilization in regenerative therapies. CH 2017;67:251-9. [DOI: 10.3233/ch-179206] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, Khan A, Mushtaq M, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Alfonso CE, Valasaki K, Pujol MV, Golpanian S, Ghersin E, Fishman JE, Pattany P, Gomes SA, Delgado C, Miki R, Abuzeid F, Vidro-Casiano M, Premer C, Medina A, Porras V, Hatzistergos KE, Anderson E, Mendizabal A, Mitrani R, Heldman AW. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. J Am Coll Cardiol. 2017;69:526-537. [PMID: 27856208 DOI: 10.1016/j.jacc.2016.11.009] [Cited by in Crossref: 175] [Cited by in F6Publishing: 159] [Article Influence: 29.2] [Reference Citation Analysis]
14 Hatzistergos KE, Saur D, Seidler B, Balkan W, Breton M, Valasaki K, Takeuchi LM, Landin AM, Khan A, Hare JM. Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways. Circ Res 2016;119:921-30. [PMID: 27481956 DOI: 10.1161/CIRCRESAHA.116.309281] [Cited by in Crossref: 68] [Cited by in F6Publishing: 43] [Article Influence: 11.3] [Reference Citation Analysis]
15 Yang W, Zhang S, Ou T, Jiang H, Jia D, Qi Z, Zou Y, Qian J, Sun A, Ge J. Interleukin-11 regulates the fate of adipose-derived mesenchymal stem cells via STAT3 signalling pathways. Cell Prolif 2020;53:e12771. [PMID: 32270546 DOI: 10.1111/cpr.12771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wysong A, Ortiz P, Bittel D, Ott L, Karanu F, Filla M, Stehno-Bittel L. Viability, yield and expansion capability of feline MSCs obtained from subcutaneous and reproductive organ adipose depots. BMC Vet Res 2021;17:244. [PMID: 34266445 DOI: 10.1186/s12917-021-02948-0] [Reference Citation Analysis]
17 Chen TJ, Yeh YT, Peng FS, Li AH, Wu SC. S100A8/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury. Int J Mol Sci 2021;22:11175. [PMID: 34681835 DOI: 10.3390/ijms222011175] [Reference Citation Analysis]
18 Bolli R, Hare JM, Henry TD, Lenneman CG, March KL, Miller K, Pepine CJ, Perin EC, Traverse JH, Willerson JT, Yang PC, Gee AP, Lima JA, Moyé L, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN). Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. Am Heart J 2018;201:54-62. [PMID: 29910056 DOI: 10.1016/j.ahj.2018.02.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Xu YC, Lin YS, Zhang L, Lu Y, Sun YL, Fang ZG, Li ZY, Fan RF. MicroRNAs of bone marrow mesenchymal stem cell-derived exosomes regulate acute myeloid leukemia cell proliferation and apoptosis. Chin Med J (Engl) 2020;133:2829-39. [PMID: 33273332 DOI: 10.1097/CM9.0000000000001138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hassanpour M, Fathi Karkan S, Rahbarghazi R, Nouri M, Amini H, Saghati S, Baradar Khoshfetrat A. Culture of rabbit bone marrow mesenchymal stem cells on polyurethane/pyrrole surface promoted differentiation into endothelial lineage. Artif Organs 2021;45:E324-34. [PMID: 33908072 DOI: 10.1111/aor.13971] [Reference Citation Analysis]
21 Yu X, Yu L, Guo B, Chen R, Qiu C. A narrative review of research advances in mesenchymal stem cell therapy for asthma. Ann Transl Med 2020;8:1461. [PMID: 33313206 DOI: 10.21037/atm-20-6389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gallagher LB, Dolan EB, O'sullivan J, Levey R, Cavanagh BL, Kovarova L, Pravda M, Velebny V, Farrell T, O'brien FJ, Duffy GP. Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions. Acta Biomaterialia 2020;107:78-90. [DOI: 10.1016/j.actbio.2020.02.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Czarna A, Sanada F, Matsuda A, Kim J, Signore S, Pereira JD, Sorrentino A, Kannappan R, Cannatà A, Hosoda T, Rota M, Crea F, Anversa P, Leri A. Single-cell analysis of the fate of c-kit-positive bone marrow cells. NPJ Regen Med 2017;2:27. [PMID: 29302361 DOI: 10.1038/s41536-017-0032-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Rady D, Abbass MMS, El-Rashidy AA, El Moshy S, Radwan IA, Dörfer CE, Fawzy El-Sayed KM. Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation. Stem Cells Int 2020;2020:8837654. [PMID: 33953753 DOI: 10.1155/2020/8837654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Yang W, Xia Y, Qian X, Wang M, Zhang X, Li Y, Li L. Co-expression network analysis identified key genes in association with mesenchymal stem cell osteogenic differentiation. Cell Tissue Res 2019;378:513-29. [PMID: 31418071 DOI: 10.1007/s00441-019-03071-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
27 Zhu W, Zhao M, Mattapally S, Chen S, Zhang J. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle. Circ Res 2018;122:88-96. [PMID: 29018036 DOI: 10.1161/CIRCRESAHA.117.311504] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 12.4] [Reference Citation Analysis]
28 Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. Mol Ther. 2018;26:1610-1623. [PMID: 29807782 DOI: 10.1016/j.ymthe.2018.05.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 23.3] [Reference Citation Analysis]
29 Jayaraman S, Gnanasampanthapandian D, Rajasingh J, Palaniyandi K. Stem Cell-Derived Exosomes Potential Therapeutic Roles in Cardiovascular Diseases. Front Cardiovasc Med 2021;8:723236. [PMID: 34447796 DOI: 10.3389/fcvm.2021.723236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wiśniewska J, Sadowska A, Wójtowicz A, Słyszewska M, Szóstek-Mioduchowska A. Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies. Life (Basel) 2021;11:1068. [PMID: 34685439 DOI: 10.3390/life11101068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kheila M, Gorjipour F, Hosseini Gohari L, Sharifi M, Aboutaleb N. Human mesenchymal stem cells derived from amniotic membrane attenuate isoproterenol (ISO)-induced myocardial injury by targeting apoptosis. Med J Islam Repub Iran 2021;35:82. [PMID: 34291006 DOI: 10.47176/mjiri.35.82] [Reference Citation Analysis]
32 Zhuang L, Xia W, Hou M. Co‑culturing with hypoxia pre‑conditioned mesenchymal stem cells as a new strategy for the prevention of irradiation‑induced fibroblast‑to‑myofibroblast transition. Oncol Rep 2019;42:1781-92. [PMID: 31485596 DOI: 10.3892/or.2019.7293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020;11. [PMID: 32374254 DOI: 10.5041/rmmj.10401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Jin L, Zhang J, Deng Z, Liu J, Han W, Chen G, Si Y, Ye P. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2. Stem Cell Res Ther. 2020;11:122. [PMID: 32183879 DOI: 10.1186/s13287-020-01633-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
35 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
36 Ali AMEA, Ahmed AS, El-Yasergy DF, Abousarie MA, Elsayed RM, Mohammed YE, Mohammed RA. Therapeutic potential of mesenchymal stem cells for peripheral artery disease in a rat model of hindlimb ischemia. Iran J Basic Med Sci 2021;24:805-14. [PMID: 34630958 DOI: 10.22038/ijbms.2021.55861.12491] [Reference Citation Analysis]
37 Zhu Q, Hao H, Xu H, Fichman Y, Cui Y, Yang C, Wang M, Mittler R, Hill MA, Cowan PJ, Zhang G, He X, Zhou S, Liu Z. Combination of Antioxidant Enzyme Overexpression and N-Acetylcysteine Treatment Enhances the Survival of Bone Marrow Mesenchymal Stromal Cells in Ischemic Limb in Mice With Type 2 Diabetes. J Am Heart Assoc 2021;10:e023491. [PMID: 34569277 DOI: 10.1161/JAHA.121.023491] [Reference Citation Analysis]
38 Fang G, Yang X, Chen S, Wang Q, Zhang A, Tang B. Cyclodextrin-based host–guest supramolecular hydrogels for local drug delivery. Coordination Chemistry Reviews 2022;454:214352. [DOI: 10.1016/j.ccr.2021.214352] [Reference Citation Analysis]
39 Zheng Z, Yu C, Wei H. Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment. Tissue Eng Part B Rev 2021;27:430-54. [PMID: 33086984 DOI: 10.1089/ten.TEB.2020.0168] [Reference Citation Analysis]
40 Deng L, Li H, Su X, Zhang Y, Xu H, Fan L, Fan J, Han Q, Bai X, Zhao RC. Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell Death Dis 2020;11:158. [PMID: 32123161 DOI: 10.1038/s41419-020-2357-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
41 Yu Z, Liu J, Fan Q, Yu J, Ren X, Wang X, Andreucci E. Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway. Analytical Cellular Pathology 2022;2022:1-19. [DOI: 10.1155/2022/9302496] [Reference Citation Analysis]
42 Wang Q, He X, Wang B, Pan J, Shi C, Li J, Wang L, Zhao Y, Dai J, Wang D. Injectable collagen scaffold promotes swine myocardial infarction recovery by long-term local retention of transplanted human umbilical cord mesenchymal stem cells. Sci China Life Sci 2021;64:269-81. [PMID: 32712833 DOI: 10.1007/s11427-019-1575-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Wang Z, Wang L, Jiang R, Li C, Chen X, Xiao H, Hou J, Hu L, Huang C, Wang Y. Ginsenoside Rg1 prevents bone marrow mesenchymal stem cell senescence via NRF2 and PI3K/Akt signaling. Free Radic Biol Med 2021;174:182-94. [PMID: 34364981 DOI: 10.1016/j.freeradbiomed.2021.08.007] [Reference Citation Analysis]
44 Zhang J, Zhu W, Radisic M, Vunjak-Novakovic G. Can We Engineer a Human Cardiac Patch for Therapy? Circ Res 2018;123:244-65. [PMID: 29976691 DOI: 10.1161/CIRCRESAHA.118.311213] [Cited by in Crossref: 69] [Cited by in F6Publishing: 35] [Article Influence: 23.0] [Reference Citation Analysis]
45 Tadevosyan K, Iglesias-García O, Mazo MM, Prósper F, Raya A. Engineering and Assessing Cardiac Tissue Complexity. Int J Mol Sci 2021;22:1479. [PMID: 33540699 DOI: 10.3390/ijms22031479] [Reference Citation Analysis]
46 Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, Wu Y, Zhang N, Qian J. Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis. Stem Cell Res Ther 2019;10:150. [PMID: 31151406 DOI: 10.1186/s13287-019-1258-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
47 Duan H, He Z, Lin M, Wang Y, Yang F, Mitteer RA, Kim HJ, Yeo E, Han H, Qin L, Fan Y, Gong Y. Plasminogen regulates mesenchymal stem cell-mediated tissue repair after ischemia through Cyr61 activation. JCI Insight 2020;5:131376. [PMID: 32759492 DOI: 10.1172/jci.insight.131376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 He J, Ping S, Yu F, Yuan X, Wang J, Qi J. Mesenchymal stem cell-derived exosomes: therapeutic implications for rotator cuff injury. Regen Med 2021;16:803-15. [PMID: 34261369 DOI: 10.2217/rme-2020-0183] [Reference Citation Analysis]
49 Florea V, Rieger AC, Natsumeda M, Tompkins BA, Banerjee MN, Schulman IH, Premer C, Khan A, Valasaki K, Heidecker B, Mantero A, Balkan W, Mitrani RD, Hare JM. The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy. Cardiovasc Res 2020;116:2131-41. [PMID: 32053144 DOI: 10.1093/cvr/cvaa004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Popescu S, Preda MB, Marinescu CI, Simionescu M, Burlacu A. Dual Stem Cell Therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of Cell Functions. Int J Mol Sci 2021;22:5631. [PMID: 34073327 DOI: 10.3390/ijms22115631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Kulandavelu S, Karantalis V, Fritsch J, Hatzistergos KE, Loescher VY, McCall F, Wang B, Bagno L, Golpanian S, Wolf A, Grenet J, Williams A, Kupin A, Rosenfeld A, Mohsin S, Sussman MA, Morales A, Balkan W, Hare JM. Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine. J Am Coll Cardiol 2016;68:2454-64. [PMID: 27908351 DOI: 10.1016/j.jacc.2016.09.925] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
52 Zhao X, Liu Y, Yu Y, Huang Q, Ji W, Li J, Zhao Y. Hierarchically porous composite microparticles from microfluidics for controllable drug delivery. Nanoscale 2018;10:12595-604. [PMID: 29938277 DOI: 10.1039/c8nr03728k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 6.3] [Reference Citation Analysis]
53 Mao Q, Liang XL, Wu YF, Pang YH, Zhao XJ, Lu YX. ILK promotes survival and self-renewal of hypoxic MSCs via the activation of lncTCF7-Wnt pathway induced by IL-6/STAT3 signaling. Gene Ther 2019;26:165-76. [PMID: 30814673 DOI: 10.1038/s41434-018-0055-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Abdeen AA, Saha K. Manufacturing Cell Therapies Using Engineered Biomaterials. Trends Biotechnol 2017;35:971-82. [PMID: 28711155 DOI: 10.1016/j.tibtech.2017.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
55 Tompkins BA, Balkan W, Winkler J, Gyöngyösi M, Goliasch G, Fernández-Avilés F, Hare JM. Preclinical Studies of Stem Cell Therapy for Heart Disease. Circ Res 2018;122:1006-20. [PMID: 29599277 DOI: 10.1161/CIRCRESAHA.117.312486] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
56 Razban V, Khajeh S, Alaee S, Mostafavi-pour Z, Soleimani M. Tube Formation Potential of BMSCs and USSCs in Response to HIF-1α Overexpression under Hypoxia. Cytol Genet 2018;52:236-44. [DOI: 10.3103/s0095452718030064] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Bahsoun S, Coopman K, Forsyth NR, Akam EC. The Role of Dissolved Oxygen Levels on Human Mesenchymal Stem Cell Culture Success, Regulatory Compliance, and Therapeutic Potential. Stem Cells and Development 2018;27:1303-21. [DOI: 10.1089/scd.2017.0291] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
58 Wu T, Xie Y, Huang J, Li P, Wang X, Yan Y, Xia T, Li L, Zhu F, Li H, Wu R. The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice. Stem Cells Int 2017;2017:3258035. [PMID: 29362568 DOI: 10.1155/2017/3258035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
59 Zhang N, Luo X, Zhang S, Liu R, Liang L, Su W, Liang D. Subconjunctival injection of tumor necrosis factor-α pre-stimulated bone marrow-derived mesenchymal stem cells enhances anti-inflammation and anti-fibrosis in ocular alkali burns. Graefes Arch Clin Exp Ophthalmol 2021;259:929-40. [PMID: 33237391 DOI: 10.1007/s00417-020-05017-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Ammar HI, Shamseldeen AM, Shoukry HS, Ashour H, Kamar SS, Rashed LA, Fadel M, Srivastava A, Dhingra S. Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats. American Journal of Physiology-Heart and Circulatory Physiology 2021;320:H1290-302. [DOI: 10.1152/ajpheart.00317.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
61 Xia W, Hou M. Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a. Oncol Lett 2018;15:10037-46. [PMID: 29928373 DOI: 10.3892/ol.2018.8438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
62 Abu-El-Rub E, Sareen N, Yan W, Alagarsamy KN, Rafieerad A, Srivastava A, Desiderio V, Dhingra S. Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells. Cell Death Dis 2020;11:419. [PMID: 32499535 DOI: 10.1038/s41419-020-2634-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
63 Kulandavelu S, Balkan W, Hare JM. Next-Generation Stem Cell Therapy: Genetically Modified Mesenchymal Stem Cells for Cardiac Repair: Editorial to: “Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction” by Leilei Chen et al. Cardiovasc Drugs Ther 2017;31:5-7. [DOI: 10.1007/s10557-017-6714-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
64 Forsberg MH, Kink JA, Hematti P, Capitini CM. Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol 2020;8:665. [PMID: 32766255 DOI: 10.3389/fcell.2020.00665] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
65 Arjmand B, Abedi M, Arabi M, Alavi-Moghadam S, Rezaei-Tavirani M, Hadavandkhani M, Tayanloo-Beik A, Kordi R, Roudsari PP, Larijani B. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Front Cell Dev Biol 2021;9:704903. [PMID: 34568321 DOI: 10.3389/fcell.2021.704903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Florea V, Bagno L, Rieger AC, Hare JM. Attenuation of frailty in older adults with mesenchymal stem cells. Mechanisms of Ageing and Development 2019;181:47-58. [DOI: 10.1016/j.mad.2019.111120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Irion CI, Martins EL, Christie MLA, de Andrade CBV, de Moraes ACN, Ferreira RP, Pimentel CF, Suhett GD, de Carvalho ACC, Lindoso RS, Vieyra A, Galina A, Goldenberg RCS. Acute Myocardial Infarction Reduces Respiration in Rat Cardiac Fibers, despite Adipose Tissue Mesenchymal Stromal Cell Transplant. Stem Cells Int 2020;2020:4327965. [PMID: 32655647 DOI: 10.1155/2020/4327965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
68 Xie DM, Chen Y, Liao Y, Lin W, Dai G, Lu DH, Zhu S, Yang K, Wu B, Chen Z, Peng C, Jiang MH. Cardiac Derived CD51-Positive Mesenchymal Stem Cells Enhance the Cardiac Repair Through SCF-Mediated Angiogenesis in Mice With Myocardial Infarction. Front Cell Dev Biol 2021;9:642533. [PMID: 33968928 DOI: 10.3389/fcell.2021.642533] [Reference Citation Analysis]
69 Oliveira MSD, Saldanha-araujo F, Goes AMD, Costa FF, de Carvalho JL. Stem cells in cardiovascular diseases: turning bad days into good ones. Drug Discovery Today 2017;22:1730-9. [DOI: 10.1016/j.drudis.2017.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
70 Tompkins BA, Rieger AC, Florea V, Banerjee MN, Hare JM. New insights into cell-based therapy for heart failure from the CHART-1 study. Eur J Heart Fail 2017;19:1530-3. [PMID: 28948676 DOI: 10.1002/ejhf.955] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
71 Gilbert HTJ, Mallikarjun V, Dobre O, Jackson MR, Pedley R, Gilmore AP, Richardson SM, Swift J. Nuclear decoupling is part of a rapid protein-level cellular response to high-intensity mechanical loading. Nat Commun 2019;10:4149. [PMID: 31515493 DOI: 10.1038/s41467-019-11923-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
72 Hoeeg C, Dolatshahi-Pirouz A, Follin B. Injectable Hydrogels for Improving Cardiac Cell Therapy-In Vivo Evidence and Translational Challenges. Gels 2021;7:7. [PMID: 33499287 DOI: 10.3390/gels7010007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
73 Hatzistergos KE, Williams AR, Dykxhoorn D, Bellio MA, Yu W, Hare JM. Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair. Circ Res 2019;124:1184-97. [PMID: 30744497 DOI: 10.1161/CIRCRESAHA.118.314063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
74 Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020. [PMID: 32519302 DOI: 10.1007/s13238-020-00738-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
75 Bektik E, Fu JD. Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming. Cells 2019;8:E679. [PMID: 31277520 DOI: 10.3390/cells8070679] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
76 Michelis KC, Nomura-Kitabayashi A, Lecce L, Franzén O, Koplev S, Xu Y, Santini MP, D'Escamard V, Lee JTL, Fuster V, Hajjar R, Reddy RC, Chikwe J, Stelzer P, Filsoufi F, Stewart A, Anyanwu A, Björkegren JLM, Kovacic JC. CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries. Stem Cell Reports 2018;11:242-57. [PMID: 30008326 DOI: 10.1016/j.stemcr.2018.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
77 Tomov ML, Gil CJ, Cetnar A, Theus AS, Lima BJ, Nish JE, Bauser-Heaton HD, Serpooshan V. Engineering Functional Cardiac Tissues for Regenerative Medicine Applications. Curr Cardiol Rep 2019;21:105. [PMID: 31367922 DOI: 10.1007/s11886-019-1178-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
78 Lin M, Liu X, Zheng H, Huang X, Wu Y, Huang A, Zhu H, Hu Y, Mai W, Huang Y. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway. Stem Cell Res Ther. 2020;11:22. [PMID: 31918758 DOI: 10.1186/s13287-019-1544-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
79 Pagano F, Picchio V, Chimenti I, Sordano A, De Falco E, Peruzzi M, Miraldi F, Cavarretta E, Zoccai GB, Sciarretta S, Frati G, Marullo AGM. On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy. Curr Cardiol Rep 2019;21:133. [PMID: 31673821 DOI: 10.1007/s11886-019-1226-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
80 Golpanian S, DiFede DL, Khan A, Schulman IH, Landin AM, Tompkins BA, Heldman AW, Miki R, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Pujol MV, Da Fonseca M, Oliva AA Jr, Green G, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Goldschmidt-Clermont PJ, Hare JM. Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci 2017;72:1505-12. [PMID: 28444181 DOI: 10.1093/gerona/glx056] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
81 Liu H, Liu S, Qiu X, Yang X, Bao L, Pu F, Liu X, Li C, Xuan K, Zhou J, Deng Z, Liu S, Jin Y. Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells. Autophagy 2020;16:2140-55. [PMID: 31959090 DOI: 10.1080/15548627.2020.1717128] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
82 Moghaddam AS, Afshari JT, Esmaeili SA, Saburi E, Joneidi Z, Momtazi-Borojeni AA. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis. 2019;285:1-9. [PMID: 30939341 DOI: 10.1016/j.atherosclerosis.2019.03.016] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 21.3] [Reference Citation Analysis]
83 Yang F, Wu R, Jiang Z, Chen J, Nan J, Su S, Zhang N, Wang C, Zhao J, Ni C, Wang Y, Hu W, Zeng Z, Zhu K, Liu X, Hu X, Zhu W, Yu H, Huang J, Wang J. Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation. Cell Death Dis 2018;9:556. [PMID: 29748581 DOI: 10.1038/s41419-018-0579-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
84 Jin Y, Kim D, Choi YJ, Song I, Chung Y. Gene Network Analysis for Osteoporosis, Sarcopenia, Diabetes, and Obesity in Human Mesenchymal Stromal Cells. Genes 2022;13:459. [DOI: 10.3390/genes13030459] [Reference Citation Analysis]
85 Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M, Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Vidro-Casiano M, Da Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Green G, Oliva AA, Hare JM. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 2017;72:1513-22. [PMID: 28977399 DOI: 10.1093/gerona/glx137] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 12.4] [Reference Citation Analysis]
86 Yin M, Zhang Y, Yu H, Li X. Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells. Front Cell Dev Biol 2021;9:665412. [PMID: 33968939 DOI: 10.3389/fcell.2021.665412] [Reference Citation Analysis]
87 Marotta P, Cianflone E, Aquila I, Vicinanza C, Scalise M, Marino F, Mancuso T, Torella M, Indolfi C, Torella D. Combining cell and gene therapy to advance cardiac regeneration. Expert Opin Biol Ther 2018;18:409-23. [PMID: 29347847 DOI: 10.1080/14712598.2018.1430762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
88 Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, Mushtaq M, Golpanian S, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Valasaki K, Pujol MV, Ghersin E, Miki R, Delgado C, Abuzeid F, Vidro-Casiano M, Saltzman RG, DaFonseca D, Caceres LV, Ramdas KN, Mendizabal A, Heldman AW, Mitrani RD, Hare JM. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121:1279-1290. [PMID: 28923793 DOI: 10.1161/circresaha.117.311827] [Cited by in Crossref: 89] [Cited by in F6Publishing: 58] [Article Influence: 17.8] [Reference Citation Analysis]
89 Banerjee MN, Bolli R, Hare JM. Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions. Circ Res 2018;123:266-87. [PMID: 29976692 DOI: 10.1161/CIRCRESAHA.118.311217] [Cited by in Crossref: 71] [Cited by in F6Publishing: 43] [Article Influence: 23.7] [Reference Citation Analysis]
90 Hou J, Wang L, Wu Q, Zheng G, Long H, Wu H, Zhou C, Guo T, Zhong T, Wang L, Chen X, Wang T. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9:109. [PMID: 29673400 DOI: 10.1186/s13287-018-0861-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
91 Zhang Z, Tan Y, Zhu L, Zhang B, Feng P, Gao E, Xu C, Wang X, Yi W, Sun Y. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway. Life Sci 2019;231:116554. [PMID: 31194992 DOI: 10.1016/j.lfs.2019.116554] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
92 Wan X, Chen S, Fang Y, Zuo W, Cui J, Xie S. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis. J Cell Physiol 2020;235:8613-25. [PMID: 32557673 DOI: 10.1002/jcp.29706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
93 Khoei SG, Dermani FK, Malih S, Fayazi N, Sheykhhasan M. The Use of Mesenchymal Stem Cells and their Derived Extracellular Vesicles in Cardiovascular Disease Treatment. Curr Stem Cell Res Ther 2020;15:623-38. [PMID: 32357818 DOI: 10.2174/1574888X15666200501235201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
94 Zheng CX, Sui BD, Hu CH, Qiu XY, Zhao P, Jin Y. Reconstruction of structure and function in tissue engineering of solid organs: Toward simulation of natural development based on decellularization. J Tissue Eng Regen Med 2018;12:1432-47. [PMID: 29701314 DOI: 10.1002/term.2676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
95 Han D, Li X, Fan WS, Chen JW, Gou TT, Su T, Fan MM, Xu MQ, Wang YB, Ma S, Qiu Y, Cao F. Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation. Oncotarget 2017;8:64853-66. [PMID: 29029396 DOI: 10.18632/oncotarget.17614] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
96 Santini MP, Malide D, Hoffman G, Pandey G, D'Escamard V, Nomura-Kitabayashi A, Rovira I, Kataoka H, Ochando J, Harvey RP, Finkel T, Kovacic JC. Tissue-Resident PDGFRα+ Progenitor Cells Contribute to Fibrosis versus Healing in a Context- and Spatiotemporally Dependent Manner. Cell Rep 2020;30:555-570.e7. [PMID: 31940496 DOI: 10.1016/j.celrep.2019.12.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
97 Kaushal S, Wehman B, Pietris N, Naughton C, Bentzen SM, Bigham G, Mishra R, Sharma S, Vricella L, Everett AD, Deatrick KB, Huang S, Mehta H, Ravekes WA, Hibino N, Difede DL, Khan A, Hare JM. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. Am Heart J 2017;192:48-56. [PMID: 28938963 DOI: 10.1016/j.ahj.2017.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
98 Schulman IH, Balkan W, Saltzman R, Dafonseca D, Caceres LV, Delgado C, Pujol MV, Ramdas KN, Tovar J, Vidro-casiano M, Hare JM. Unique Aspects of the Design of Phase I/II Clinical Trials of Stem Cell Therapy. In: Abdeldayem H, editor. The Management of Clinical Trials. InTech; 2018. [DOI: 10.5772/intechopen.72949] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
99 Blázquez-Prunera A, Almeida CR, Barbosa MA. Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium. Stem Cells Int 2017;2017:2185351. [PMID: 28588620 DOI: 10.1155/2017/2185351] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
100 Ramesh S, Govarthanan K, Ostrovidov S, Zhang H, Hu Q, Camci-Unal G, Verma RS, Ramalingam M. Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers. Stem Cell Rev Rep 2021;17:1343-61. [PMID: 33864233 DOI: 10.1007/s12015-021-10165-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Cui X, He Z, Liang Z, Chen Z, Wang H, Zhang J. Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway. J Cardiovasc Pharmacol 2017;70:225-31. [PMID: 28582278 DOI: 10.1097/FJC.0000000000000507] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 19.0] [Reference Citation Analysis]
102 Yan W, Guo Y, Tao L, Lau WB, Gan L, Yan Z, Guo R, Gao E, Wong GW, Koch WL, Wang Y, Ma XL. C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways. Circulation 2017;136:2162-77. [PMID: 28978553 DOI: 10.1161/CIRCULATIONAHA.117.029557] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 12.8] [Reference Citation Analysis]
103 Matsushita K. Heart Failure and Adipose Mesenchymal Stem Cells. Trends Mol Med 2020;26:369-79. [PMID: 32277931 DOI: 10.1016/j.molmed.2020.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Park JM, Han YM, Hahm KB. Rejuvenation of Helicobacter pylori-Associated Atrophic Gastritis Through Concerted Actions of Placenta-Derived Mesenchymal Stem Cells Prevented Gastric Cancer. Front Pharmacol 2021;12:675443. [PMID: 34483897 DOI: 10.3389/fphar.2021.675443] [Reference Citation Analysis]
105 Rochette L, Mazini L, Malka G, Zeller M, Cottin Y, Vergely C. The Crosstalk of Adipose-Derived Stem Cells (ADSC), Oxidative Stress, and Inflammation in Protective and Adaptive Responses. Int J Mol Sci 2020;21:E9262. [PMID: 33291664 DOI: 10.3390/ijms21239262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
106 Liu Z, Mikrani R, Zubair HM, Taleb A, Naveed M, Baig MMFA, Zhang Q, Li C, Habib M, Cui X, Sembatya KR, Lei H, Zhou X. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations. Eur J Pharmacol 2020;876:173049. [PMID: 32142771 DOI: 10.1016/j.ejphar.2020.173049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
107 Yuan Y, Du W, Liu J, Ma W, Zhang L, Du Z, Cai B. Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles. Front Pharmacol 2018;9:547. [PMID: 29904347 DOI: 10.3389/fphar.2018.00547] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
108 Patino-Guerrero A, Veldhuizen J, Zhu W, Migrino RQ, Nikkhah M. Three-dimensional scaffold-free microtissues engineered for cardiac repair. J Mater Chem B 2020;8:7571-90. [PMID: 32724973 DOI: 10.1039/d0tb01528h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
109 Zeng Z, Yu K, Hu W, Cheng S, Gao C, Liu F, Chen J, Kong M, Zhang F, Liu X, Wang J. SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts. Stem Cells Dev 2021;30:386-98. [PMID: 33567991 DOI: 10.1089/scd.2020.0149] [Reference Citation Analysis]
110 Chen L, Samanta A, Zhao L, Dudley NR, Buehler T, Vincent RJ, Hauptman J, Girgis M, Dawn B. Vitamin D3 induces mesenchymal-to-endothelial transition and promotes a proangiogenic niche through IGF-1 signaling. iScience 2021;24:102272. [PMID: 33817577 DOI: 10.1016/j.isci.2021.102272] [Reference Citation Analysis]
111 Feng YM, Verfaillie C, Yu H. Vascular Diseases and Metabolic Disorders. Stem Cells Int 2016;2016:5810358. [PMID: 27833643 DOI: 10.1155/2016/5810358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
112 Kang K, Chuai J, Xie B, Li J, Qu H, Wu H, Fang S, Cui J, Xiu L, Han J, Cao T, Leng X, Tian H, Li R, Jiang S. Mesenchymal Stromal Cells from Patients with Cyanotic Congenital Heart Disease are Optimal Candidate for Cardiac Tissue Engineering. Biomaterials 2020;230:119574. [DOI: 10.1016/j.biomaterials.2019.119574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
113 Yang D, Liu HQ, Yang Z, Fan D, Tang QZ. BMI1 in the heart: Novel functions beyond tumorigenesis. EBioMedicine 2021;63:103193. [PMID: 33421944 DOI: 10.1016/j.ebiom.2020.103193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 He JG, Li HR, Li BB, Xie QL, Yan D, Wang XJ. Bone marrow mesenchymal stem cells overexpressing GATA-4 improve cardiac function following myocardial infarction. Perfusion 2019;34:696-704. [PMID: 31090492 DOI: 10.1177/0267659119847442] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Liu H, Deng S, Han L, Ren Y, Gu J, He L, Liu T, Yuan ZX. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces 2021;209:112163. [PMID: 34736220 DOI: 10.1016/j.colsurfb.2021.112163] [Reference Citation Analysis]
116 Kang JJH, Bozso SJ, El-Andari R, Moon MC, Freed DH, Nagendran J, Nagendran J. Sternal Bone Marrow Harvesting and Culturing Techniques from Patients Undergoing Cardiac Surgery. Micromachines (Basel) 2021;12:897. [PMID: 34442518 DOI: 10.3390/mi12080897] [Reference Citation Analysis]
117 Chen J, Zhan Y, Wang Y, Han D, Tao B, Luo Z, Ma S, Wang Q, Li X, Fan L, Li C, Deng H, Cao F. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. Acta Biomaterialia 2018;80:154-68. [DOI: 10.1016/j.actbio.2018.09.013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 22.8] [Reference Citation Analysis]
118 Redgrave RE, Tual-Chalot S, Davison BJ, Singh E, Hall D, Amirrasouli MM, Gilchrist D, Medvinsky A, Arthur HM. Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis. Stem Cell Reports 2017;8:1287-98. [PMID: 28494939 DOI: 10.1016/j.stemcr.2017.04.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
119 Bolli R, Solankhi M, Tang XL, Kahlon A. Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts. Cardiovasc Res 2021:cvab135. [PMID: 33871588 DOI: 10.1093/cvr/cvab135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
120 Yan W, Lin C, Guo Y, Chen Y, Du Y, Lau WB, Xia Y, Zhang F, Su R, Gao E, Wang Y, Li C, Liu R, Ma XL, Tao L. N-Cadherin Overexpression Mobilizes the Protective Effects of Mesenchymal Stromal Cells Against Ischemic Heart Injury Through a β-Catenin-Dependent Manner. Circ Res 2020;126:857-74. [PMID: 32079489 DOI: 10.1161/CIRCRESAHA.119.315806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
121 Warrier S, Mohana Sundaram S, Varier L, Balasubramanian A. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19? Placenta 2021;117:161-8. [PMID: 34915433 DOI: 10.1016/j.placenta.2021.12.005] [Reference Citation Analysis]
122 Deng R, Law AHY, Shen J, Chan GC. Mini Review: Application of Human Mesenchymal Stem Cells in Gene and Stem Cells Therapy Era. Curr Stem Cell Rep 2018;4:327-37. [DOI: 10.1007/s40778-018-0147-3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
123 Nasser MI, Qi X, Zhu S, He Y, Zhao M, Guo H, Zhu P. Current situation and future of stem cells in cardiovascular medicine. Biomed Pharmacother 2020;132:110813. [PMID: 33068940 DOI: 10.1016/j.biopha.2020.110813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Mochizuki N, Pearson JT, Kitamura S. Beyond proof of concepts for ideal cardiac regenerative therapy. J Thorac Cardiovasc Surg 2017;154:964-5. [PMID: 28645824 DOI: 10.1016/j.jtcvs.2017.05.015] [Reference Citation Analysis]
125 Sabry D, Mostafa A, Marzouk S, Ibrahim W, Ali HHM, Hassan A, Shamaa A. Neupogen and mesenchymal stem cells are the novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats. Biosci Rep 2017;37:BSR20170794. [PMID: 28883083 DOI: 10.1042/BSR20170794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
126 Gao Y, Stanley DV, Robinson VC, Reid DM, Galis ZS. Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015. Circ Res 2017;120:1713-7. [PMID: 28546354 DOI: 10.1161/CIRCRESAHA.117.310735] [Reference Citation Analysis]
127 Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy. J Am Heart Assoc 2018;7:e008460. [PMID: 30005555 DOI: 10.1161/JAHA.117.008460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
128 Yang J, Gao J, Gao F, Zhao Y, Deng B, Mu X, Xu L. Extracellular vesicles-encapsulated microRNA-29b-3p from bone marrow-derived mesenchymal stem cells promotes fracture healing via modulation of the PTEN/PI3K/AKT axis. Exp Cell Res 2022;:113026. [PMID: 35026284 DOI: 10.1016/j.yexcr.2022.113026] [Reference Citation Analysis]
129 Fernandes GC, Fernandes ADF, Rivera M, Khan A, Schulman IH, Lambrakos LK, Myerburg RJ, Goldberger JJ, Hare JM, Mitrani RD. A meta‐analysis of arrhythmia endpoints in randomized controlled trials of transendocardial stem cell injections for chronic ischemic heart disease. J Cardiovasc Electrophysiol 2019;30:2492-500. [DOI: 10.1111/jce.14185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
130 Gao L, Yi M, Xing M, Li H, Zhou Y, Xu Q, Zhang Z, Wen Z, Chang J. In situ activated mesenchymal stem cells (MSCs) by bioactive hydrogels for myocardial infarction treatment. J Mater Chem B 2020;8:7713-22. [PMID: 32724972 DOI: 10.1039/d0tb01320j] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
131 Yang Z, Li Y, Wang Z. Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies. Pharmaceutics 2022;14:618. [DOI: 10.3390/pharmaceutics14030618] [Reference Citation Analysis]
132 Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, Ma N. Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci. 2019;76:1681-1695. [PMID: 30721319 DOI: 10.1007/s00018-019-03019-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
133 Zhang Z, Zhu L, Feng P, Tan Y, Zhang B, Gao E, Wang X, Fan C, Wang X, Yi W, Sun Y. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction. Cell Death Dis 2019;10:530. [PMID: 31296837 DOI: 10.1038/s41419-019-1760-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
134 Hoeeg C, Frljak S, Qayyum AA, Vrtovec B, Kastrup J, Ekblond A, Follin B. Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review. Biomedicines 2020;8:E570. [PMID: 33291410 DOI: 10.3390/biomedicines8120570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
135 Marbán E. A mechanistic roadmap for the clinical application of cardiac cell therapies. Nat Biomed Eng 2018;2:353-61. [PMID: 30740264 DOI: 10.1038/s41551-018-0216-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
136 Lin Y, Zhu W, Chen X. The involving progress of MSCs based therapy in atherosclerosis. Stem Cell Res Ther 2020;11:216. [PMID: 32503682 DOI: 10.1186/s13287-020-01728-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Joshi J, Xu B, Rubart M, Chang Y, Bao X, Chaliki HP, Scott LR, Zhu W. Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study. Cells 2022;11:951. [DOI: 10.3390/cells11060951] [Reference Citation Analysis]
138 Lyu T, Zhang B, Li M, Jiao X, Song Y. Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies. Hematol Oncol 2021;39:162-9. [PMID: 32869900 DOI: 10.1002/hon.2793] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Sylvester CB, Pugazenthi A, Grande-Allen KJ, Ghanta RK. Cell-Laden Bioactive Poly(ethylene glycol) Hydrogels for Studying Mesenchymal Stem Cell Behavior in Myocardial Infarct-Stiffness Microenvironments. Cardiovasc Eng Technol 2021;12:183-99. [PMID: 33432513 DOI: 10.1007/s13239-020-00515-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Fish KM, Ishikawa K, Hajjar RJ. Stem cell therapy for acute myocardial infarction: on the horizon or still a dream? Coron Artery Dis 2018;29:89-91. [PMID: 29140809 DOI: 10.1097/MCA.0000000000000589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
141 Bagno LL, Salerno AG, Balkan W, Hare JM. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method. Expert Opin Biol Ther 2021;:1-15. [PMID: 34882517 DOI: 10.1080/14712598.2022.2016695] [Reference Citation Analysis]
142 Chen Y, Li C, Li C, Chen J, Li Y, Xie H, Lin C, Fan M, Guo Y, Gao E, Yan W, Tao L. Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice. J Am Heart Assoc 2020;9:e013784. [PMID: 31955638 DOI: 10.1161/JAHA.119.013784] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
143 Mochizuki M, Nakahara T. Establishment of xenogeneic serum-free culture methods for handling human dental pulp stem cells using clinically oriented in-vitro and in-vivo conditions. Stem Cell Res Ther 2018;9:25. [PMID: 29394956 DOI: 10.1186/s13287-017-0761-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
144 Yu K, Zeng Z, Cheng S, Hu W, Gao C, Liu F, Chen J, Qian Y, Xu D, Zhao J, Liu X, Wang J. TPP1 Enhances the Therapeutic Effects of Transplanted Aged Mesenchymal Stem Cells in Infarcted Hearts via the MRE11/AKT Pathway. Front Cell Dev Biol 2020;8:588023. [PMID: 33195247 DOI: 10.3389/fcell.2020.588023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Hatzistergos KE, Vedenko A. Cardiac Cell Therapy 3.0: The Beginning of the End or the End of the Beginning? Circ Res 2017;121:95-7. [PMID: 28684618 DOI: 10.1161/CIRCRESAHA.117.311293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
146 Kawamura M, Paulsen MJ, Goldstone AB, Shudo Y, Wang H, Steele AN, Stapleton LM, Edwards BB, Eskandari A, Truong VN, Jaatinen KJ, Ingason AB, Miyagawa S, Sawa Y, Woo YJ. Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy. Cardiovasc Diabetol 2017;16:142. [PMID: 29096622 DOI: 10.1186/s12933-017-0625-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
147 Broughton KM, Sussman MA. Cardiac tissue engineering therapeutic products to enhance myocardial contractility. J Muscle Res Cell Motil 2020;41:363-73. [PMID: 31863324 DOI: 10.1007/s10974-019-09570-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Lei T, Deng S, Chen P, Xiao Z, Cai S, Hang Z, Yang Y, Zhang X, Li Q, Du H. Metformin enhances the osteogenesis and angiogenesis of human umbilical cord mesenchymal stem cells for tissue regeneration engineering. Int J Biochem Cell Biol 2021;141:106086. [PMID: 34551339 DOI: 10.1016/j.biocel.2021.106086] [Reference Citation Analysis]
149 Zhang C, Zhou G, Chen Y, Liu S, Chen F, Xie L, Wang W, Zhang Y, Wang T, Lai X, Ma L. Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways. Mol Med Rep 2018;17:71-8. [PMID: 29115435 DOI: 10.3892/mmr.2017.7882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
150 Bao X, Wang J, Zhou G, Aszodi A, Schönitzer V, Scherthan H, Atkinson MJ, Rosemann M. Extended in vitro culture of primary human mesenchymal stem cells downregulates Brca1-related genes and impairs DNA double-strand break recognition. FEBS Open Bio 2020;10:1238-50. [PMID: 32333827 DOI: 10.1002/2211-5463.12867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
151 Chen X, Wu J, Sun R, Zhao Y, Li Y, Pan J, Chen Y, Wang X. Tubular scaffold with microchannels and an H-shaped lumen loaded with bone marrow stromal cells promotes neuroregeneration and inhibits apoptosis after spinal cord injury. J Tissue Eng Regen Med 2020;14:397-411. [PMID: 31821733 DOI: 10.1002/term.2996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
152 Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P, Djalilian AR. Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells. 2018;36:775-784. [PMID: 29341332 DOI: 10.1002/stem.2781] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
153 Landin AM, Hare JM. The quest for a successful cell-based therapeutic approach for heart failure. Eur Heart J 2017;38:661-4. [PMID: 28073861 DOI: 10.1093/eurheartj/ehw626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
154 Crisostomo V, Baez C, Abad JL, Sanchez B, Alvarez V, Rosado R, Gómez-Mauricio G, Gheysens O, Blanco-Blazquez V, Blazquez R, Torán JL, Casado JG, Aguilar S, Janssens S, Sánchez-Margallo FM, Rodriguez-Borlado L, Bernad A, Palacios I. Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells. Stem Cell Res Ther 2019;10:152. [PMID: 31151405 DOI: 10.1186/s13287-019-1237-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
155 Streeter BW, Davis ME. Therapeutic Cardiac Patches for Repairing the Myocardium. In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 5. Cham: Springer International Publishing; 2019. pp. 1-24. [DOI: 10.1007/5584_2018_309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
156 Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, Gao L, Xie J, Xu B. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115:1205-1216. [PMID: 30753344 DOI: 10.1093/cvr/cvz040] [Cited by in Crossref: 136] [Cited by in F6Publishing: 150] [Article Influence: 68.0] [Reference Citation Analysis]
157 Lemcke H, Voronina N, Steinhoff G, David R. Recent Progress in Stem Cell Modification for Cardiac Regeneration. Stem Cells Int 2018;2018:1909346. [PMID: 29535769 DOI: 10.1155/2018/1909346] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
158 Chernyak BV. Mitochondrial Transplantation: A Critical Analysis. Biochemistry (Mosc) 2020;85:636-41. [PMID: 32571194 DOI: 10.1134/S0006297920050132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
159 Chen S, Carlson MA, Li X, Siddique A, Zhu W, Xie J. Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair. ACS Biomater Sci Eng 2021;7:2204-11. [PMID: 33929841 DOI: 10.1021/acsbiomaterials.1c00344] [Reference Citation Analysis]
160 Tang WY, Liu JH, Peng CJ, Liao Y, Luo JS, Sun X, Tang YL, Luo XQ. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus. Arch Immunol Ther Exp (Warsz) 2021;69:7. [PMID: 33713197 DOI: 10.1007/s00005-021-00603-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]